FZFujie ZhangMD, PhDSlidesetHIVChinese HIV Clinical Forum 2022Fujie Zhang - HIV Low-Level Viremia and New Approach to Drug Resistance SurveillanceView Slideset
MBMarta BoffitoMD, PhD, FRCP, MBASlidesetHIVChinese HIV Clinical Forum 2022Marta Boffito - Stopping/Switching Considerations When Using La-ARVsView Slideset
LDLili DaiPhDSlidesetHIVChinese HIV Clinical Forum 2022Lili Dai - Rapid ART Initiation Using BIC/FTC/TAF and TDF+3TC+EFV in HIV Positive Patients in China: A Randomized Controlled TrialView Slideset
LDLili DaiPhDVideoHIVChinese HIV Clinical Forum 2022Rapid ART Initiation Using BIC/FTC/TAF and TDF+3TC+EFV in HIV Positive Patients in China: A Randomized Controlled Trial - Lili Dai, PhDView Video
CHChien-Ching HungMD, PhDVideoHIVChinese HIV Clinical Forum 2022International Data Supporting Rapid Start - Chien-Ching Hung, MD, PhDView Video
MBMarta BoffitoMD, PhD, FRCP, MBAVideoHIVChinese HIV Clinical Forum 2022Stopping/Switching Considerations When Using La-ARVs - Marta Boffito, MD, PhD, FRCPView Video
JMJean-Michel MolinaMD, PhDVideoHIVChinese HIV Clinical Forum 2022Update on Long Acting Therapeutic Options for HIV Treatment - Jean-Michel Molina, MD, PhDView Video
NPNicholas PatonMD, FRCPVideoHIVChinese HIV Clinical Forum 2022Switching to Newer (Reduced) Drug Regimens in Patients Suppressed on Older Drugs - Nicholas Paton, MD, FRCPView Video
ACAndrea CalcagnoMD, DTM&HVideoHIVChinese HIV Clinical Forum 2022Pharmacological Considerations in Choice of Regimen - Andrea Calcagno, MD, DTM&HView Video
FZFujie ZhangMD, PhDVideoHIVChinese HIV Clinical Forum 2022HIV Low-Level Viremia and New Approach to Drug Resistance Surveillance - Fujie Zhang, MD, PhDView Video
KRKiat RuxrungthamMDVideoHIVChinese HIV Clinical Forum 2022Resistance Considerations in Choice of Regimen - Kiat Ruxrungtham, MDView Video
PPPraphan PhanuphakMD, PhDSlidesetHIVRSVAsia-Pacific HIV Clinical Forum 2022Early Diagnosis and Same-day ARTView Slideset
